Access to Affordable Cancer Drugs

Share

Fighting cancer is a struggle. Getting access to the lifesaving cancer drugs you need – at a price you can afford - shouldn't be.

Too many cancer patients face barriers in getting health insurance coverage for the prescription drugs recommended by their oncologist. And then, oftentimes, even when coverage is there, their share of the cost can bust the household budget.

We must find new solutions to make cancer drugs more accessible and affordable for cancer patients - whether through new regulations or laws passed by Congress and your state legislature.
 

56% of cancer patients and survivors are worried about being able to afford their treatment

Take Action

sad patient

Secretary Azar: Don't delay access to lifesaving medicine for cancer patients

Tell Health & Human Services Secretary Azar: Don't delay access to lifesaving medicine for cancer patients! Stop the proposed changes to Medicare Part D's Six Protected Classes.

Latest Updates

March 28, 2019
National

A new nationwide survey of cancer patients, caregivers and doctors details the negative effects insurance utilization management policies in private insurance have had on patient care and what those policies could mean should proposed changes to Medicare’s Part D’s “six protected classes” prescription drug coverage policy go into effect.

February 5, 2019
National

Cancer patients, survivors and caregivers will tune into the president’s State of the Union address to see if the president will commit to strengthen the nation's health care system, support life-saving medical research and improve quality of life for patients.

January 28, 2019
National

On Friday the American Cancer Society Cancer Action Network (ACS CAN) along with nearly 60 other patient advocacy organizations sent a letter to the Department of Health and Human Services (HHS) about how proposed changes to Medicare Part D’s six protected classes could hurt cancer patients’ timely access to drug

January 25, 2019
National

Today the American Cancer Society Cancer Action Network (ACS CAN) submitted comments to the Department Health and Human Services (HHS) detailing ways in which proposed changes to Medicare Part D’s six protected classes could jeopardize cancer patients’ timely access to drug therapies.

Access to Affordable Cancer Drugs Resources

ACS CAN is very concerned about proposed policy changes that would move coverage of cancer and supportive care drugs from Part B to Part D. Proposed policy changes could jeopardize patient access to drugs, create potential safety issues, and increase out-of-pocket costs for patients who already struggle to afford cancer treatment under the current Medicare program.

In 2003, Congress passed the Medicare Modernization Act (MMA), which created an outpatient prescription drug benefit in the Medicare program. Known as Part D, the prescription benefit is operated exclusively through private insurance plans that contract with Medicare. To ensure that beneficiaries have coverage for the drugs they need Part D plans are required to cover at least two drugs in each therapeutic class. A therapeutic class is a group of medications that are used to treat the same condition. 

Pharmacy benefit managers (PBMs) are entities that administer prescription drug programs for many private, public, and employer health insurance plans. PBMs establish pharmacy networks, negotiate prices with pharmaceutical manufacturers on behalf of their clients, and provide basic claims administration.